Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive heart failure: a pilot study.

Luan H, Chen X, Zhong S, Yuan X, Meng N, Zhang J, Fu J, Xu R, Lee C, Song S, Jiang H, Xu X.

Biomarkers. 2013 Jun;18(4):314-21. doi: 10.3109/1354750X.2013.781222. Epub 2013 Apr 12.

PMID:
23581255
2.

Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.

Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, Marella GA, Colombi C, Foschini A, Valoti P, Mossello E, Fumagalli S, Marchionni N, Tarantini F.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):292-9. doi: 10.1016/j.numecd.2011.03.012. Epub 2011 Oct 26.

PMID:
22032915
3.

Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry.

Glauser J, Erickson J, Bhatt D, Lindsell C, Gibler B, Hoekstra J, Pollack C, Hollander J, Peacock WF.

Congest Heart Fail. 2007 May-Jun;13(3):142-8.

4.

Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease.

Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, Dong T, Yuan Y, Yuan X, Zhang M, Xie N, Zhang H, Dong H, Dong W.

Mol Cell Proteomics. 2012 Aug;11(8):370-80. doi: 10.1074/mcp.M111.016006. Epub 2012 Apr 13.

5.

Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?

Eisen A, Benderly M, Goldbourt U, Haim M.

Clin Cardiol. 2013 Feb;36(2):110-6. doi: 10.1002/clc.22083. Epub 2013 Jan 17.

6.

Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.

Takashio S, Yamamuro M, Izumiya Y, Sugiyama S, Kojima S, Yamamoto E, Tsujita K, Tanaka T, Tayama S, Kaikita K, Hokimoto S, Ogawa H.

J Am Coll Cardiol. 2013 Aug 13;62(7):632-40. doi: 10.1016/j.jacc.2013.03.065. Epub 2013 May 1.

7.

1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients.

Du Z, Shen A, Huang Y, Su L, Lai W, Wang P, Xie Z, Xie Z, Zeng Q, Ren H, Xu D.

PLoS One. 2014 Feb 5;9(2):e88102. doi: 10.1371/journal.pone.0088102. eCollection 2014.

8.

Exploratory investigation reveals parallel alteration of plasma fatty acids and eicosanoids in coronary artery disease patients.

Xu YJ, Ho WE, Xu F, Wen T, Ong CN.

Prostaglandins Other Lipid Mediat. 2013 Oct;106:29-36. doi: 10.1016/j.prostaglandins.2013.08.003. Epub 2013 Sep 2.

PMID:
24007966
9.

Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.

Sueta CA, Massing MW, Chowdhury M, Biggs DP, Simpson RJ Jr.

J Card Fail. 2003 Feb;9(1):36-41.

PMID:
12612871
10.

Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate.

Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA.

Am Heart J. 2003 Jul;146(1):62-8.

PMID:
12851609
11.

Resistin level in coronary artery disease and heart failure: the central role of kidney function.

Baldasseroni S, Mannucci E, Di Serio C, Orso F, Bartoli N, Mossello E, Foschini A, Monami M, Valoti P, Fumagalli S, Colombi C, Pellerito S, Gensini G, Marchionni N, Tarantini F.

J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):150-7. doi: 10.2459/JCM.0b013e32834eec93.

PMID:
22240747
12.

Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.

Zhang X, Xu L, Shen J, Cao B, Cheng T, Zhao T, Liu X, Zhang H.

Biochim Biophys Acta. 2013 Aug;1832(8):1207-16. doi: 10.1016/j.bbadis.2013.03.009. Epub 2013 Mar 20.

13.

Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure.

Watson CJ, Ledwidge MT, Phelan D, Collier P, Byrne JC, Dunn MJ, McDonald KM, Baugh JA.

Circ Heart Fail. 2011 Mar;4(2):188-97. doi: 10.1161/CIRCHEARTFAILURE.110.952200. Epub 2011 Jan 31.

14.

Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training.

Yan B, A J, Wang G, Lu H, Huang X, Liu Y, Zha W, Hao H, Zhang Y, Liu L, Gu S, Huang Q, Zheng Y, Sun J.

J Appl Physiol (1985). 2009 Feb;106(2):531-8. doi: 10.1152/japplphysiol.90816.2008. Epub 2008 Nov 26.

15.

Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.

Safranow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A, Jakubowska K, Olszewska M, Loniewska B, Kaliszczak R, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D.

Scand J Clin Lab Invest. 2009;69(1):102-12. doi: 10.1080/00365510802430964.

PMID:
18855224
16.

The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease.

Sakatani T, Shirayama T, Suzaki Y, Yamamoto T, Mani H, Kawasaki T, Sugihara H, Matsubara H.

Int Heart J. 2005 Jul;46(4):619-29.

17.

Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease.

Li Q, Lu Y, Sun L, Yan J, Yan X, Fang L, Li M, Fan Z.

Metabolism. 2012 Dec;61(12):1803-8. doi: 10.1016/j.metabol.2012.06.001. Epub 2012 Jul 11.

PMID:
22789446
18.

Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality.

Øie E, Ueland T, Dahl CP, Bohov P, Berge C, Yndestad A, Gullestad L, Aukrust P, Berge RK.

J Intern Med. 2011 Sep;270(3):263-72. doi: 10.1111/j.1365-2796.2011.02384.x. Epub 2011 May 3.

19.

High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?

Uzunlulu M, Oğuz A, Tigen K.

Anadolu Kardiyol Derg. 2005 Dec;5(4):268-70.

20.

The association of serum prolidase activity with the presence and severity of coronary artery disease.

Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, Aksoy N, Ocak AR, Erel O.

Coron Artery Dis. 2008 Aug;19(5):319-25. doi: 10.1097/MCA.0b013e32830042ba.

PMID:
18607169
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk